Serum Matrix Metalloproteinase‐7 is an independent prognostic biomarker in advanced bladder cancer
Abstract Background Urine markers have been studied extensively but there is a lack of blood prognostic markers in bladder cancer. MMP‐7 is produced by stromal cells and by tumor cells and is overexpressed in a variety of epithelial and mesenchymal tumors. In this study, we assessed with an immunoas...
Main Authors: | Mounira El Demery, Gaiané Demirdjian‐Sarkissian, Simon Thezenas, William Jacot, Yassine Laghzali, Bruno Darbouret, Stéphane Culine, Xavier Rebillard, Pierre‐Jean Lamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40169-014-0031-4 |
Similar Items
-
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
by: Jacek Kudelski, et al.
Published: (2021-08-01) -
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
by: Chien-Chang Li, et al.
Published: (2020-01-01) -
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
by: Libo Yang, et al.
Published: (2021-08-01) -
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
by: Hiroshi Fukushima, et al.
Published: (2018-10-01) -
Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma
by: I-Hung Shao, et al.
Published: (2016-04-01)